Table 4.
Summary of MS data from α-cardiac myosin extracted from mouse hearts
Tg WT RLCTg K104E RLC
Protein (%)   
Mouse WT RLC 4.3 ± 1.8 46.6±5.1 
Human WT RLC 95.7 ± 1.8 — 
Human K104E RLC — 53.4 ± 5.1 
α-Cardiac myosin (Myh698.3 ± 0.5 97.1 ± 1.7 
Peptidea   
IEGGSpSNVFSMFEQTQIQEFK (mRLC, singly phosphorylated) 10.0 ± 5.6 5.1 ± 0.3 
IEGGSpSpNVFSMFEQTQIQEFK (mRLC, doubly phosphorylated) 0.6 ± 0.3 0.3 ± 0.1 
AGGANSpNVFSMFEQTQIQEFK (hRLC, phosphorylated) 11.9 ± 10.4 3.4 ± 1.2 
Tg WT RLCTg K104E RLC
Protein (%)   
Mouse WT RLC 4.3 ± 1.8 46.6±5.1 
Human WT RLC 95.7 ± 1.8 — 
Human K104E RLC — 53.4 ± 5.1 
α-Cardiac myosin (Myh698.3 ± 0.5 97.1 ± 1.7 
Peptidea   
IEGGSpSNVFSMFEQTQIQEFK (mRLC, singly phosphorylated) 10.0 ± 5.6 5.1 ± 0.3 
IEGGSpSpNVFSMFEQTQIQEFK (mRLC, doubly phosphorylated) 0.6 ± 0.3 0.3 ± 0.1 
AGGANSpNVFSMFEQTQIQEFK (hRLC, phosphorylated) 11.9 ± 10.4 3.4 ± 1.2 

All data are averages ± SD where n = 3. hRLC, human RLC; mRLC, murine RLC.

a

Data are expressed as the ratio of the phosphopeptide and the nonphosphopeptide. These ratios do not account for the difference in the ionization efficiencies between the peptides and should not be interpreted as absolute phosphorylation levels.

or Create an Account

Close Modal
Close Modal